This document describes a cancer tissue array that provides a cost- and time-efficient platform for biomarker discovery and validation. The array features pre-arrayed tissues selected by pathologists from various cancer types, including kidney, liver, lung and more. Tissues are collected under ethical practices and clinical data is provided. The array allows for high-throughput screening of genes or proteins and includes normal tissues as controls.